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HORIZONTAL DEVIATION OF RETINAL NERVE FIBER LAYER PEAK 
THICKNESS WITH STRATUS OPTICAL COHERENCE TOMOGRAPHY IN 
GLAUCOMA. 
Jennifer C. Lee and M. Bruce Shields.  Department of Ophthalmology and Visual 
Sciences, Yale University School of Medicine, New Haven, CT 
 We hypothesized that nasal or temporal peak contour shifts from the normative 
database observed on the Fast retinal nerve fiber layer (RNFL) scan is a common 
occurrence because there is a range of distribution of peak contours due to anatomical 
variation, not necessarily related to glaucoma, and this displacement may lead to 
misclassification as glaucoma under current commercial optical coherence tomography 
(OCT) criteria.  The purpose of this study was to evaluate the prevalence these shifts with 
Stratus OCT and possible associations with demographic or glaucoma-related variables.   
This was a retrospective case series of glaucoma patients and glaucoma suspects 
(one eye per patient) who underwent a Fast RNFL thickness study with the Stratus OCT.  
A study was considered to have a clinically significant horizontal deviation if there was 
greater than 20
o
 shift from the normative database in both superior and inferior peaks.  A 
second cut-off value of 12
o
 was also used to examine smaller deviations.  A linear 
regression model was used to assess correlations of demographic and glaucoma-related 
variables between eyes with and without significant deviations.   
Of 400 subjects screened, 273 met the inclusion criteria.  Thirty-nine eyes 
(14.3%) had clinically significant horizontal deviation using the 20
o
 cut-off (95%CI 10%-
19%), while 122 (44.7%) met the definition with the 12
o
 cut-off (95%CI 38%-51%).  
Additionally, 121 eyes (44.3%) had a >20
o
 horizontal shift of either the superior or 
inferior peak (95% CI 38%-51%).  There was no correlation between the demographic or 
glaucoma-related variables and the horizontal deviation of peak contours.   
This study suggests that significant horizontal deviation of peak RNFL contours 
with the Stratus OCT Fast RNFL is common and emphasizes the need for caution when 
interpreting the influence of such deviations on clock hour segment thinning.  It is not 
possible with this technology to distinguish between scan circle misalignment (horizontal 
or vertical) and anatomical variation as the explanation for the finding, and further study 
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Glaucoma is a progressive optic atrophy, characterized by loss of retinal ganglion 
cells and tissue remodeling of the optic nerve head (Fig. 1).  There are currently two main 
theories on the pathophysiology of glaucomatous optic neuropathy—a mechanical 
(pressure) and vascular (ocular blood flow) theory.  The mechanical and vascular theories 
have been defended by various research groups since Smith in 1885 (1) first suggested 
that mechanical and vascular factors were involved in glaucoma pathogenesis (2).   
Glaucoma was first described as a disease involving ―firmness of the eyeball‖ and 
early physicians in the field considered increased intraocular pressure (IOP) the 
―essence‖ of glaucoma (2,3).  According to the mechanical theory, increased intraocular 
pressure damages the laminar cribrosa by stretching the lamina beams and damaging the 
retinal ganglion cell axons, either directly by the pressure gradient or indirectly by tissue 
deformation (2,4).  The presence of congenital glaucoma and angle-closure glaucoma 
indicate that increased IOP is sufficient to cause glaucomatous optic neuropathy.  
Furthermore, studies have shown a beneficial effect of eye pressure lowering therapy, 
even in normal tension glaucoma patients.  Pressure lowering therapy, however, only 
slows the progression of glaucomatous optic neuropathy, and cannot reverse preexisting 
optic nerve damage or stop progression all together.  In addition, normal tension 
glaucoma patients and patients with ocular hypertension but no glaucomatous nerve 
damage cannot be explained by the mechanical theory alone.     
The vascular theory is based on the observation that a reduction of ocular blood 
flow often precedes the development of glaucomatous optic neuropathy.  Ocular blood 




blood flow in the eye and mild repeated reperfusion injury via oxidative stress.  The 
human eye can actually tolerate a constant reduction of blood flow (e.g. atherosclerosis, 
multiple sclerosis) to a certain level, without glaucomatous optic neuropathy, before an 
infarction occurs.  It has been shown that fluctuating intraocular pressure is more 
damaging to the optic nerve head than a stable increase in intraocular pressure (5).  
Therefore, it is hypothesized that fluctuations in perfusion leads to oxidative stress 
(reperfusion injury) and eventually glaucomatous optic neuropathy (6).   
Patients with systemic primary vascular dysregulation respond differently to 
stimuli and constrict their vessels more than others, including the vessels in the back of 
the eye (6).  The theory that glaucoma is caused by a blood flow dysfunction is supported 
by data showing that blood flow is not only reduced in all areas of the eyes (iris, retina, 
optic nerve, choroids) in glaucoma patients but also in the capillaries of their fingers, 
pointing to a global vascular dysregulation.  The insufficient autoregulation of blood 
vessels in the back of the eye reduces ocular blood flow leading to ischemia and 
reperfusion injury by reactive oxygen species, increasing the risk for glaucomatous optic 
neuropathy overtime (2). 
In glaucoma patients, oxidative stress appears to play a dual role damaging both 
the trabecular meshwork and retina ganglion cells.  Oxidative stress occurs when 
prooxidant induced damage exceeds the antioxidant repair capacity.  Antioxidants are 
composed of enzymes, such as superoxide dismutase, gluthatione peroxidase and 
catalase, as well as molecules such as glutathione, flavonoids and vitamins C and E.  It is 
thought that glaucoma patients have decreased antioxidant enzyme capacity in the 




more susceptible to reactive oxygen species induced damage.  One study showed that 
DNA damage is higher in the trabeular meshwork cells of glaucoma patients compared to 
age-matched controls (8). 
Prior work on glaucoma pathophysiology assumed that the increased intraocular 
pressure observed in glaucoma patients is secondary to a decline in trabecular meshwork 
cellularity (9).  The current thinking is that oxidative stress contributes to trabecular 
meshwork cellular degeneration, specifically the endothelial cells, which subsequently 
decreases aqueous outflow, and as a result causes increased intraocular pressure (10).  A 
strong correlation between the degree of oxidative DNA damage in the trabecular 
meshwork and subsequent increased intraocular pressure and visual field defects has been 
shown in glaucoma patients with primary open-angle glaucoma (11).  Thus, increased 
IOP in primary open angle is likely in part due to increased resistance to outflow through 
the trabecular meshwork (6).   
Endothelins also appear to play a role in the regulation of intraocular pressure 
independent of the trabecular meshwork (10).  Endothelin levels are elevated in the 
aqueous humor of glaucoma patients compared to healthy controls (12).  Specifically, 
endothelin-1 appears to be the mediator in reducing optic nerve blood flow (13) leading 
to retinal ganglion cell death, independent of elevated intraocular pressure (14).  
Activation of endothelin receptors induces changes in the retinal ganglion cell axonal 
transport system leading to retinal ganglion cell apoptosis (10).    
Unstable ocular blood flow in the retinal ganglion cells lead to oxidative stress 
and the production of oxygen free radicals.  Ischemic stress activates astrocytes 




nitric oxide (NO) combines with an oxygen free radical produced by the retinal ganglion 
cell, peroxynitrat (ONOO
-
) is formed.  The peroxynitrat (ONOO
-
) diffuses into the retinal 
ganglion axons and lateral geniculate nucleus and induce apoptosis (6).  Furthermore, 
there is a high concentration of mitochondria in the optic nerve head.  Mitochondrial 
respiratory function declines with age and leads to increased production of oxygen free 
radicals by the mitochondria (15).  Repeated mild reperfusion injury leads to chronic 
oxidative stress on the mitochondria, making them age faster and produce more oxygen 
free radicals, setting up a vicious cycle (6).   
 Aspects of both the mechanical and vascular theories interplay together in an 
individual patient to cause glaucomatous optic neuropathy.  The mechanical theory was 
historically the original theory, but recent technological advances allowing measurement 
of ocular blood flow has yielded evidence that supports a vascular theory based on 
fluctuating ocular blood flow.  The pressure theory alone does not explain normal tension 
glaucomatous optic neuropathy and why patients with ocular hypertension do not suffer 
glaucomatous optic neuropathy.  There must be other mediating factors that make certain 
individuals more susceptible to damage by increased ocular pressure.  Known glaucoma 
risk factors include myopia, sex, race, genetics, and autoimmune diseases (2).  
Differentiation between the two theories in practice is moot because the only widely 
available clinical treatments for glaucoma at present are ocular pressure lowering 
therapies.  Perhaps with a better understanding of the pathophysiology of glaucoma, 
newer treatments will become available that target blood flow modulation or boost 




Abnormalities of the retinal nerve fiber layer (RNFL) are among the earliest signs 
of glaucomatous optic neuropathy (16).  Visual field (VF) testing and stereoscopic optic 
nerve head (ONH) photography have traditionally been used to diagnose and follow 
glaucoma progression.  However, retinal nerve fiber loss precedes visual field loss (17) 
and nearly half of the retinal ganglion cells in the retina may be lost before abnormalities 
in optic nerve head (ONH) appearance are noted (18,19).   As retinal ganglion cells are 
lost, the retinal nerve fiber layer (RNFL) thins (20).  Measurement of RNFL thickness 
has been shown to be more sensitive than visual fields or ONH photography in detecting 
early glaucoma (17,21).   
There are currently three commercially available technologies for diagnostic 
imaging of the RNFL that is FDA approved for use in clinical practice: a confocal 
scanning laser ophthalmoscope (Heidelberg Retina Tomograph (HRT)), a scanning laser 
polarimeter (GDx) and an optical coherence tomograph (OCT).  Each technology uses 
different properties of light and different characteristics of the retinal tissue to obtain 
RNFL thickness measurements.  The models of each technology most studied in the 
literature will be reviewed in this paper, which are the HRTII (Heidelberg Engineering, 
Dossenheim, Germany), GDx Variable Corneal Compensation (VCC) (Carl Zeiss 
Meditec Inc., Vista, CA), and Stratus OCT (Carl Zeiss Meditec Inc., Dublin, CA) (Table 
1, Table 2).  Each instrument also includes an age-adjusted normative database for 
comparison (22) since RNFL thinning also occurs with aging.  Furthermore, each 
technology has been shown to adequately differentiate normal eyes from glaucomatous 
eyes (23, 24, 25).  There are more advanced models for each technology available, 




is very little evidenced-based literature available on the use of these models in clinical 
practice, and thus their clinical usage will not be discussed.     
The ability of each technology to differentiate between normal eyes and 
glaucomatous eyes is often presented as the area under the receiver operator curve 
(AUROC) value, rather than sensitivity and specificity alone.  The AUROC is a graphical 
plot of the sensitivity versus (1-specificity) for a binary classification system.  This curve 
can also be represented equivalently by plotting the fraction of true positive (sensitivity) 
versus the fraction of false positives (1-specificity), however when presented this way, 
the value is referred to as the Relative Operating Characteristic (ROC) curve.  The value 
for the AUROC ranges from 0.5 to 1, with 1 having the highest ability to discriminate 





Table 1: Differences between diagnostic imaging technologies for RNFL thickness 
measurements (28) 







Stratus OCT RNFL thickness 
around ONH 
7-8μm inferior RNFL 
(0.92) 
None ~$61,950 
GDx VCC RNFL thickness  
around ONH 















OCT optical coherence tomography; VCC variable corneal compensation;   
HRT Heidelberg Retina Tomograph;  RNFL retinal nerve fiber layer; ONH optic nerve 





Table 2: Pros and Cons between diagnostic imaging technologies for RNFL thickness 
measurements 
Instrument Pros Cons 
Stratus 
OCT 
Ability to differentiate 
between layers of the 
retina, retina and glaucoma 
applications 
Operator drawn optic-disc margin, 
RNFL thickness limited to circle around 
ONH and not parapapillary region, requires 
pupil dilation, no progression analysis  
GDx VCC No pupil dilation Atypical birefringence pattern in older 
patients, irregularities in cornea or macular 
architecture can alter retardation, only 
measures RNFL thickness 
HRT II Parapapillary retina 
tomographic map  
Operator drawn optic-disc margin, 
magnification correction, reference plane 
OCT optical coherence tomography; VCC variable corneal compensation;   
HRT Heidelberg Retina Tomograph;  RNFL retinal nerve fiber layer; ONH optic nerve 
head 
 
ONH diagnostic imaging technologies 
Scanning laser polarimetry (GDx) (26):  
Scanning laser polarimetry (SLP) utilizes reflected polarized light (780nm) 
undergoing a phase shift (retardation) corresponding to the amount of birefringent tissue 
(neurotubules within ganglion cell axons) passed in the retina, which is proportional to 




thickness proportionally, it is susceptible to confounding birefringence by non-RNFL 
structures in the eye (mainly from the cornea).  Therefore it is necessary to compensate 
for the birefringence of these structures in order to reduce interference with RNFL 
thickness measurements.  Newer models of SLP (GDx VCC) have better algorithms to 
compensate for corneal birefringence.  Most recently, the GDx ECC provides individual 
compensation for corneal birefringence.  The RNFL Temporal-Superior-Nasal-Inferior-
Temporal (TSNIT) profile is generated from a 3.2mm calculation circle centered on the 
ONH (27), but the nerve fiber indicator (NFI), value (from 0 to 100) representing the 
likelihood of glaucoma diagnosis, is based on the entire RNFL thickness map.  Among 
the various standard GDx VCC parameters, the NFI parameter has the best diagnostic 
accuracy with AUC values ranging from 0.89 (preperimetric) to 0.94 (perimetric loss) 
(27, 28,29).  RNFL contour measurements are compared to a normative database to 
determine areas of change.   
 
Confocal scanning laser ophthalmoscopy (CSLO) (HRT) (30): 
The CSLO utilizes a diode laser (670 nm wavelength) to sequentially scan the 
retinal surface in the x and y plane at 64 consecutive equidistant focal planes along the z-
axis (optic nerve axis) to create a three-dimensional topographic map of the retinal 
surface which provides calculations of peripapillary retinal height measurements and cup-
to-disc ratio.  RNFL thickness around the ONH is calculated by measuring the distance 
between the mean height contour and an individual based reference plane, as this 
instrument does not different between layers of the retina (22).  Surface height 




the glaucoma probability score (GPS), which combines five parameters (two RNFL 
parameters and three optic disc parameters) to provide the probability of having 
glaucoma (Fig. 2).  Using the HRT I, Zanwill et al. (23) found the AUROC ranged from 
0.75 to 0.96.    
 
Optical Coherence Tomography (OCT) (30): 
OCT uses low-coherence laser interferometry (850nm) to examine light 
backscattered from individual layers of the retina with differing optical densities, which 
is analogous to ultrasound imaging except using light instead of sound.  This technology 
can differentiate between layers of the retina using edge detection algorithms to give 
RNFL thickness measurements.  The Stratus OCT Fast RNFL scan provides 3 scans, 
each scan includes 256 equally spaced A-scans (2 dimensional axial cross-sectional 
image) along a 360
o
 scan circle (3.4mm) centered around the ONH.  The RNFL values 
are compared to an aged-matched normative database and deviations reported as sectoral 
thinning (Fig. 3).   
RNFL inferior thickness and average thickness have the best diagnostic accuracy 
of the Stratus OCT RNFL measurement parameters (28, 32).  Combining the results from 
multiple studies correlating glaucoma diagnosis with OCT RNFL measurements, mean 
RNFL thickness in the superior and inferior quadrants had the highest AUROC with 0.79 
to 0.95 for the superior quadrant and 0.86 to 0.97 for the inferior quadrant (27, 33, 34, 
35).  AUROC values comparing glaucoma suspects with controls were lower than the 
values of glaucoma patients with VF loss, ranging from 0.59 to 0.84 for the superior 




The newest commercially available version of OCT is spectral domain(SD)-OCT 
(Cirrus HD-OCT, Carl Zeiss Meditec, Inc. Dublin, CA) which has much faster scanning, 
better axial resolution, and eliminates the need for operator centering of the ONH 
compared to the previous time domain (TD)-OCT (Stratus OCT) (Table 3).  SD-OCT 
collects all the backscattered light frequencies simultaneously (hence ―spectral domain‖).  
This version uses a broad bandwidth light source to achieve low coherence.  Since each 
frequency of light represents a different tissue depth, the frequencies of reflections can be 
mapped to individual retinal layers (20).  The SD-OCT algorithm creates a virtual 3.4mm 
scan circle around the ONH after processing the scan data, allowing for precise centration 
of the scan circle around the ONH.  Furthermore, decreased acquisition time reduces 
motion artifact from minuscule eye movements during scanning.  One possible 
explanation for variable measurements obtained with TD-OCT is varying placement of 
the scan circle around the ONH, giving slightly different measurements each time.  






Table 3: Time domain OCT versus Spectral domain OCT (20) 
Version Resolution A-scans/second Scan circle 
placement 




10-15μm 400 Operator 
center disc 
margin 
Immediately before  
Spectral 
domain 
3-6um 24,000-55,000 Virtual via 
algorithm  
Simultaneous  
 OCT optical coherence tomography; ONH optic nerve head 
 
Comparison of the three RNFL imaging technologies: 
There are a number of barriers to directly comparing diagnostic accuracy between 
the three imaging technologies.  A limited number of published studies exist that compare 
multiple imaging modalities in the same patient (28, 36, 37, 38, 39, 40, 41).  Furthermore, 
it is problematic comparing results across different studies because there are varying 
criteria for glaucoma diagnosis (e.g. glaucomatous VF defect versus glaucomatous 
change in the optic disc) and varying degrees of glaucoma severity in each study.  
Studies comparing HRT versus GDx VCC and OCT versus HRT showed good 
intra-instrument correlation (40, 41), however the values are not interchangeable between 
instruments (27, 38).  One study comparing Stratus OCT and GDx VCC found that OCT 
RNFL values correlated with visual function better than GDx VCC RNFL values in 
regression analysis (34).  Furthermore, the same study found Stratus OCT RNFL 




both normal and glaucoma eyes (39).  Despite this difference however, the best 
diagnostic parameter for each instrument had equal AUROC values (0.901 for Stratus 
OCT and 0.909 for GDx VCC) (39).  A study by Schuman et al. (41) found similar 
AUROC values for Status OCT and HRTI.   
At present, there is only one study directly comparing all three technologies.  In 
this study, Medeiros et al. (28) found no significant difference in the diagnostic accuracy 
(AUROC) of the best parameters for each technology: GDx VCC (Nerve Fiber Indicator) 
0.91, Stratus OCT (inferior quadrant) 0.92 and HRTII (linear discriminant function) 0.86 
(Table 1).  Therefore, with the current algorithms, no one imaging device does better than 
the other available technologies in distinguishing glaucoma patients from control subjects 
and in predicting glaucoma progression.  SLP (GDx) is less commonly used than HRT 
and OCT in clinical practice because its clinical applicability is limited to measuring 
RNFL thickness.  However, the GDx and HRT both provide glaucoma likelihood values 
(i.e. Nerve Fiber Indicator for GDx and Glaucoma Probability Score for HRT) which 
may be useful clinically.  Newer versions of the present technologies and better 
algorithms on the horizon are likely to provide better resolution, diagnostic accuracy, and 
progression analysis. 
 
Utility of diagnostic imaging in predicting the development of glaucoma or 
progression analysis: 
 There have only been a handful of longitudinal studies on the ability of diagnostic 
imaging of the RNFL to predict the development of visual field changes or document 




barrier to conducting longitudinal prospective studies is the rapidly evolving technology 
and the inability to compare (incompatible) measurements between different versions of 
the same technology.  Glaucoma, a chronic progressive disease, requires longitudinal 
follow-up with a standardized baseline measurement for comparison.  Clinical 
practitioners agree that disease progression analysis is crucial to the management of 
glaucoma.        
A number of studies have reported the ability of HRT to document glaucoma 
progression using topographic change analysis within the disc margin (45, 46, 47).  
Topographic change analysis compares the baseline ONH topograph with subsequent 
scans.  According to the Confocal Scanning Laser Ophthalmoscopy (CSLO) ancillary 
study to the Ocular Hypertension Treatment Study (OHTS), abnormal mean height 
contour HRTII measurements at baseline have been associated with the development of 
glaucomatous optic disc and visual field progression in ocular hypertensive eyes without 
optic disc or visual field damage at baseline (46).  Two longitudinal prospective studies 
using HRTI followed glaucoma patients who had glaucomatous VF loss at baseline 
measuring optic disc changes, standard automated perimetry (SAP) and high-pass 
resolution perimtery.  The authors found a large number of patients progressed by 
perimetry or HRT alone (42, 43).  Of note, the HRTIII model has backward 
compatibility, which means it is able to incorporate ONH measurements from prior 
models, and therefore progression analysis studies with the HRTIII are forthcoming.  At 
present, HRT RNFL measurements alone have not been shown to predict the 




A longitudinal study using a prototype OCT model on glaucoma patients and 
glaucoma suspects showed a greater likelihood of glaucomatous progression identified by 
OCT (arbitrarily defined as change of 20 μm) compared with automated perimetry 
(arbitrarily defined as 2 dB MD) over a 4.7 year period (44).  It is unclear, however, 
whether these detected changes reflect OCT false positive (hypersensitivity) results or 
glaucomatous damage identified by OCT before detection by conventional methods (SAP 
or clinical assessment).  The authors also found a portion of patients that progressed by 
OCT (21.9%) or VF (9.4%) alone. 
Currently there are no studies available on the ability of baseline GDx VCC or 
Stratus OCT RNFL measurements to predict the development of glaucoma or identify the 
progression of disease.  The RNFL baseline measurement in an older version of the GDx 
Nerve Fiber Analyzer with fixed corneal compensation was predictive of the 
development of visual field loss in glaucoma suspect eyes (48).  Similarly, thinner (10μm 
average) superior and inferior baseline RNFL measurements in a prior OCT model was 
associated with the development of glaucomatous change (VF damage or optic 
neuropathy) in glaucoma suspects over a 4 year period (49).  Glaucoma progression 
analysis software is currently being developed and tested for the Stratus OCT using trend 
analysis and event analysis. 
The only validated model that estimates the 5 year risk of conversion from ocular 
hypertension to glaucoma derived from the Ocular Hypertension Treatment Study (50) 
does not include RNFL measurements derived from peripapillary imaging.  The 
demographic and clinical factors included in the model are age, race, sex, intraocular 




horizontal cup-disc ratio and VF pattern standard deviation.  This same model was 
applied to a different untreated cohort in the Diagnostic Innovations in Glaucoma Study 
with similar results except for the presence of diabetes mellitus (51).    
 
Does use of diagnostic imaging improve disease management or diagnosis?  
At present, diagnostic imaging of the optic nerve and peripapillary RNFL is only 
used as an adjunct to VF testing and ONH stereophotography for glaucoma diagnosis and 
management.  There is widespread use of peripapillary imaging in glaucoma without 
clear evidence as to whether diagnostic imaging actually improves disease management 
or early diagnosis.  Diagnostic imaging can provide additional information not available 
via ONH photography, such as objective quantitative structural measurements of the 
peripapillary RNFL, but the present versions of these technologies are not sufficient to 
replace ONH photography for following glaucoma progression.    
There are many potential utilities of diagnostic imaging as the technology 
continues to improve.  Given the inherent variability in clinician ONH drawings and 
interpretation of ONH stereophotography, RNFL imaging can provide an objective 
documentation of baseline quantitative peripapillary RNFL measurements which can then 
be referenced in subsequent office visits.  In addition, diagnostic imaging allows 
comparison of a patient’s RNFL measurements with an aged-matched normative database 
(since thinning also occurs with aging).  RNFL abnormalities occur in early glaucoma 
before VF changes noted on standard automated perimetry (SAP) (52).  RNFL thinning 
may be the earliest structural change clinically detectable as RNFL thinning has been 




Glaucomatous changes may initially be subtle, and diagnostic imaging can 
provide more sensitive measures of  RNFL changes which may lead to earlier diagnosis 
of glaucoma suspects, before changes are noted on VF testing and ONH photography.  
Two studies on glaucoma progression both showed higher rates of glaucoma progression 
using RNFL structural analysis compared to standard automated perimetry (SAP); 44%-
82% by HRT versus 33%-57% by SAP and 25% by OCT versus 12% by SAP 
respectively (43, 44).  Another important potential usage of diagnostic imaging is to 
objectively quantify glaucoma progression and predict VF changes.  Progression analysis 
software is currently under development for each technology.  Theoretically, diagnostic 
imaging can detect subtle changes in the RNFL in a shorter period of time, however, 
there are not enough longitudinal studies to support this claim.   
The current gold standard for glaucoma diagnosis is documented VF change and 
ONH thinning observed on stereoscopic photography, which is a crude measure of RNFL 
damage.  With more sensitive measures of RNFL thickness allotted by imaging, rather 
than waiting for VF changes or ONH thinning, clinicians may need to reconsider the 
criteria for glaucoma diagnosis.  If they lower their threshold for starting medical 
treatment, they may be able to prevent progression to VF changes.  Relying on imaging 
for diagnosis, however, can give false positive results and result in over-treatment of 
glaucoma suspects.  It is standard practice to obtain 3 abnormal VF results before giving 
the diagnosis of glaucoma, but there is no common standard in imaging to perform repeat 
imaging to establish a baseline RNFL measurement.  Furthermore, all imaging 
technologies assume the patient has a normal retina because their measurements are 




inherently have abnormal RNFL measurements when compared to the normative 
database.  Consequently, clinicians should not base treatment decisions on one imaging 
result and should ensure the results fit with the clinical picture (i.e. structure-function 
concordance).  A major draw back of RNFL imaging is that none of the current 
technologies allow for the detection of optic disc hemorrhage (54), thus ONH 
photography remains a crucial part of glaucoma management.  
Studies have shown good agreement between RNFL measurements and VF 
testing and ONH photography.  There are many cases, however, where peripapillary 
imaging suggestive of glaucomatous changes are not correlated with VF changes or 
damage on ONH photography (i.e. structure-function discordance) (42, 43, 44).  This 
discrepancy may be indicative of early glaucoma, false positive results or independent 
predictors of glaucoma (22, 27).  Furthermore, there are a number of cases where 
observed VF or ONH damage resulted in normal RNFL measurements in the same 
patient (42, 43).  These inconsistencies raise questions whether diagnostic imaging 
measures different retinal ganglion cell properties than those measured in functional VF 
testing (55) (Table 4).  Diagnostic imaging provides objective quantitative assessment of 
the peripapillary structure and the cup-to-disc ratio while VF testing gives functional 
assessment of the optic nerve and fundus photography provides qualitative assessment of 
ONH cupping (the width of nerve fiber loss).  Therefore, the three test results may not 
exactly correlate, giving rise to observed structure-function discordance.  These 
discrepancies raise the question of whether early structural damage detected by RNFL 





Table 4: Optic disc photography versus RNFL imaging 
















objective structural No potentially potentially 
A
GDx VCC, HRTII, Stratus OCT 
 
Purpose of study: 
There is increasing use of computerized image analysis of the RNFL, especially 
OCT, to aid in the diagnosis and management of glaucoma, highlighting the need for 
accurate interpretation of the results of this evolving technology.  The Stratus OCT Fast 
RNFL scan provides a normative database with thickness percentile values of normal 
eyes, against which the patient’s RNFL thickness contour is compared (56). Contours that 
approach or pass the <5
th
 percentile (yellow zone) are viewed with suspicion as 
abnormally thin RNFL.  If the superior or inferior peak contour is displaced nasally or 
temporally from that of the normative database, for whatever reason, one slope of the 
contour may cut into the <5
th
 percentile, suggesting RNFL thinning, even though the 
amplitude of the peak contour may be well within the 95
th
 percentile (Fig. 4). This could 
represent true thinning or could result from misalignment of the scan circle or possibly 




peak RNFL thickness.  To our knowledge, this potential source of misinterpreting OCT 
findings (―technology created glaucoma‖) has not been emphasized in the literature.   
We hypothesized that nasal or temporal peak contour shifts from the normative 
database observed on the Fast RNFL scan is a common occurrence because there is a 
range of distribution of peak contours due to anatomical variation, not necessarily related 
to glaucoma, and this displacement may lead to misclassification as glaucoma under 
current commercial OCT criteria (comparing an individual’s RNFL measurements to a 
normative database) resulting in over aggressive treatment for glaucoma.   
The purpose of this study was to evaluate how common significant horizontal 
peak contour shifts with the Stratus OCT Fast RNFL may be in a practice with glaucoma 
patients and glaucoma suspects, to explore whether demographic or glaucoma-related 
variables are associated with this finding and to emphasize the importance of this finding 




Materials and Methods: 
This was a retrospective case series of consecutive patients seen at the Yale Eye 
Center, Department of Ophthalmology and Visual Science, New Haven, CT.  The 
inclusion criteria were glaucoma patients and glaucoma suspects who underwent a 
Stratus OCT Fast RNFL study between October 2007 and August 2008.  Exclusion 
criteria comprised of patients under 20 years of age (normative database is not available 
below this age), a superior or inferior peak contour amplitude < 100μm (peak of the 
contour is difficult to identify below this amplitude), signal strength of less than 6 
(analysis algorithms may fail on scans with low signal strength <5),  and poor scan circle 
centration (>50% difference between edge of the optic disc and scan circle, temporally 
and nasally, as well as superiorly and inferiorly) (i.e. translational misalignment).  One 
eye from each subject was selected for analysis using the ―random sample of cases‖ 
function in SPSS, although both eyes were studied to determine bilaterality of findings, 
and the most recent test was chosen for patients who had more than one test.  The study 
was approved by the Yale University Human Investigation Committee and conforms to 
the Declaration of Helsinki research on human subjects and HIPPA.   
A Stratus OCT 3000 system (Carl Zeiss Meditec, Dublin, CA) with the Fast 
RNFL scan pattern and Stratus software version 4.0 was used to obtain the 
circumpapillary RNFL thickness profile.  Details of this system are described elsewhere 
(31, 56, 57).  The patient’s RNFL is differentiated from other retinal layers using an edge 
detection algorithm (version A4X1), and the RNFL thickness for 360º around the disc 
(scan circle diameter of 3.4 mm) is defined as the number of pixels between its anterior 




averaged for each eye to produce the thickness report.  The RNFL thickness report 
includes the fundus image and scan circle centration, peripapillary retinal cross section 
image, and RNFL thickness profiles against age stratified normal values derived from 
manufacturer averages of healthy eyes (Fig. 3).  However, the exact times at which the 
scan circle centration image and the thickness profiles were acquired were not 
simultaneous.  
An experienced technician centered the scan circle around the optic disc and 
obtained the Fast RNFL studies.  One of us (JCL) evaluated each study on a digital 
monitor, assessing signal strength, scan circle centration, amplitude and horizontal 
position of the superior and inferior peak contours against the aged-matched normative 
database.  The horizontal distance between the peaks of the patient’s RNFL profile and 
that of the normative database was measured digitally using EyeRoute software (Topcon 
Medical Systems, Inc., Paramus, NJ) which allows measurement of distances in mm, 
which we then converted to degrees.  Each horizontal sampling segment (distance 
between tick marks along the x-axis) comprised of 10 A-scans (total 256 A-scans equally 
spaced along the 360
o 





*10/256)  (Fig. 5).  A significant horizontal shift of the peak contour was defined as 
20
o
 (1.7mm) or greater nasal or temporal to the corresponding peak contour of the 
normative database.  This cut-off value was selected because it is likely to be associated 
with one slope of the RNFL contour falling into the <5
th
 percentile zone.  An eye was 
considered to have a clinically significant horizontal deviation if there was a 20
o
 or 
greater shift of both the superior and inferior peaks (Fig. 5).  A second cut-off value of 
12
o




Subjects who met the inclusion-exclusion criteria, but did not have significant 
horizontal deviation in either eye, were randomly selected (using the ―random sample of 
cases‖ function in SPSS) as controls for comparing demographic and glaucoma-related 
variables between eyes with and without significant horizontal deviation.  Demographic 
variables studied were age (years), race (Caucasian, African American and other) and 
sex, while glaucoma-related variables included cup-disc ratio (C/D), neural rim (even, 
focal thinning or focal absence) and pattern standard deviation (PSD) obtained from a 
Humphrey SITA 24-2 visual field.  The C/D was derived from ophthalmoscope 
examination measured vertically and calculated as a ratio of the diameters.  Fisher exact 
χ
2
 tests were used to compare the categorical variables (sex, race and neural rim) between 
eyes with and without significant horizontal deviation, as well as the direction of peak 
contour shift (temporal vs. nasal) in those eyes with significant deviation.  Mann-Whitney 
U t-tests were used to compare the continuous variables (age, C/D and PSD) between 
eyes with and without significant horizontal deviation.   A linear regression, including the 
variables of age, race, sex, C/D, neural rim and PSD, was performed using the ―enter‖ 
method, in which all variables in a block are entered in a single step into the model.  
Level of significance was set with α=0.05.  SPSS V14.0 was used for statistical analysis.  
This study design was a joint collaboration between MBS and JCL.  JCL prepared 
HIC forms, collected clinical data, performed statistical analysis of data, and prepared the 
manuscript.  Pam Ossario from the Department of Ophthalmology and Visual Sciences 





Of 400 subjects screened, 273 subjects met the inclusion and exclusion criteria.  
Thirty-nine of the 273 eyes met the criteria for significant horizontal contour deviation 
using the 20
o
 cut-off value, giving a prevalence of 14.3% (95%CI 10%-19%), while 122 
subjects had significant deviation with the 12
o
 cut-off, increasing the prevalence to 44.7% 
(95%CI 38%-51%).  Bilateral significant deviation was seen in four subjects using the 
20
o
 cut-off and in 18 with the 12
o
 cut-off.  An additional 121 subjects had a significant 
horizontal shift (20
o
) in either the superior or inferior peak, giving a prevalence of 44.3% 
(95%CI 38%-51%), with 48 superior shifts and 76 inferior.  Seven of these 121 subjects 
had bilateral significant shifts (20
o
) in the superior quadrant and 14 in the inferior 
quadrant, while three subjects had a superior shift in one eye and an inferior shift in the 
fellow eye (resulting in 124 significant shifts in 121 subjects).  
Tables 5 and 6 show the prevalence of the direction of superior and inferior peak 
contour shifts and the average and range of the shifts in degrees for the 39 subjects that 
met the criteria for significant horizontal deviation at the 20
o
 cut-off.  Tables 7 and 8 
show the same information for the 122 subjects that met the criteria at the 12
o
 cut-off.  
The direction of peak shifts in eyes that met the 20
o
 cut-off was nasal in 20, temporal in 
13 and mixed (one peak temporal and one nasal) in 6 eyes (p=0.02), while that for the 
eyes meeting the 12
o
 cut-off was more evenly distributed with 45 nasal, 40 temporal and 





Table 5: Horizontal shift distribution with 20
o
 cut-off. 





Nasal 20 7.3% 51.3% 0.02 (χ
2
) 
Temporal 13 4.8% 33.3% 
Mixed
C 
6 2.2% 15.4% 
Total 39 14.3  
A
percentage in total population (n=273) 
B
percentage of significant horizontal deviations (n=39) 
C
one peak (superior or inferior) was displaced nasally and the other temporally 
 































































 or more shift nasal or temporal to the corresponding peak contour of the normative 




Table 7: Horizontal shift distribution with 12
o
 cut-off. 





Nasal 45 16.5% 36.9% 0.67 (χ
2
) 
Temporal 40 14.7% 32.8% 
Mixed
C 
37 13.6% 30.3% 
Total 122 44.7%  
A




 horizontal deviations (n=122)  
C
one peak (superior or inferior) was displaced nasally and the other temporally 
 


































































 or more shift nasal or temporal to the corresponding peak contour of the normative 




When comparing eyes with and without significant horizontal deviation (20
o
), 
there was no significant difference in the direction of the shifts between the two groups 
(Table 9).   
 







Superior (nasal) 64.1% 64.4% 1.00 (χ
2
) 






 or more shift nasal or temporal to the corresponding peak contour of the normative 
database in both the superior and inferior peaks 
 
Furthermore, there was no statistically significant difference in demographics 
variables or glaucoma-related variables (Table 10) between eyes with and without 
significant horizontal deviation.  The presence of a significant horizontal deviation did 
not correspond with glaucoma diagnosis when using optic nerve head thinning as the 
―gold standard‖, as evidenced by the high false positive rate (49%) and false negative rate 
(58%) observed (Table 11).  A linear regression model incorporating the demographic 
and glaucoma-related variables revealed no significant factors.   





Table 10: Comparison of demographics and glaucoma-related variables in subjects with 







Age (years, SD) 64.0 (14.1)  65.9(13.4) 0.52 (t-test) 
Female 64.4% 64.1% 1.00 (χ
2
) 
Caucasian 78.1% 73.0% 0.42 (χ
2
) 
African American 14.6% 21.6% 
Neural rim (even)  66.7% 60.0% 0.17 (χ
2
) 
C/D (SD) 0.60 (0.17) 0.64 (0.16) 0.33 (t-test) 
PSD (SD) 3.63 (2.92) 2.80 (2.23) 0.15 (t-test) 
SD (standard deviation), Neural rim (graded even, focal thinning or focal absence), C/D 




 or more shift nasal or temporal to the corresponding peak contour of the normative 











  Glaucoma suspect 
(+)shift 13 26 
(-)shift 18 27 
Total 31 53 
A
Positive clinical test based on significant deviation of 20
0
 or more shift nasal or 
temporal to the corresponding peak contour of the normative database in both the 
superior and inferior peaks 
B
―Gold standard‖ for glaucoma diagnosis based on optic nerve head neural rim thinning 
(either focal thinning or focal absence) 
false positive rate= 49%  
 






The diagnostic accuracy of the imaging derived RNFL measurements is generally 
good in differentiating glaucoma from normal eyes with no significant difference 
between the best parameters of each instrument (HRT, GDx, OCT).  There are varying 
AUROC values reported for each instrument due to the range of criteria used for 
glaucoma diagnosis, the patient population (control, ocular hypertensive or glaucoma), 
and the specific algorithm used for analysis in each study.  Since glaucoma remains a 
clinical diagnosis, it will be difficult to reach consensus criteria for glaucoma diagnosis.   
The advantage of OCT is that it directly measures RNFL thickness, while GDx and HRT 
indirectly measure RNFL thickness.  However, the GDx and HRT both provide glaucoma 
likelihood scores which have great clinical utility.   
With multiple technologies available, it is important that the ophthalmologist 
understand the strengths and weaknesses of each type of instrument and the type of data 
provided in order to correctly interpret the relevant data from the test results and 
appropriately integrate the information into glaucoma management.  The influence of 
scan circle misalignment on both the amplitude and horizontal position of RNFL 
thickness peak contours in relation to the normative database has been described with the 
Stratus OCT (58, 59) and with ultrahigh-resolution OCT (60).  A vertical misalignment 
can cause the amplitude of one peak, i.e., superior or inferior, to be artificially elevated, 
while the opposite quadrant is artificially reduced.  For example, if the scan circle is 
misaligned superiorly, i.e., the circle is closer to the inferior edge of the ONH, the 
superior peak will be artificially reduced and the inferior artificially elevated.  A 




peak contours in relation to that of the normative database. Nasal misalignment, i.e., with 
the circle closer to the temporal edge of the ONH, is associated with a temporal shift of 




While horizontal shift of RNFL thickness peak contours in relation to that of the 
normative database is known to be a potential artifact with the Stratus OCT Fast RNFL 
study, we are not aware of an emphasis in the literature on the importance of this finding 
with regard to interpretation of the data nor how often it may be seen in clinical practice. 
The purpose of our study and report is to address these latter issues.  
 
            A significant horizontal shift of a contour peak can influence the interpretation of 
the data, since one slope of the contour may cut into the <5
th
 percentile of the database, 
suggesting abnormal RNFL thinning in that area, despite a peak amplitude that is well 
within the 95
th
 percentile.  In some cases, this could represent true, focal RNFL thinning, 
while in other cases, the shift may be an artifact due to misalignment of the scan circle, as 
described above, which could create a false impression of thinning (technology created 
RNFL thinning).  Another as yet unproven, explanation for the contour shift could be an 
anatomical variation from the average in the axis of a person’s peak RNFL thickness in 
the superior-temporal and inferior-temporal quadrants.  Such variations might produce 
horizontal shifts of peak contour large enough to create a false impression of RNFL 
thinning in healthy eyes.  We are unable to substantiate this theoretical explanation in our 
present study, because the Stratus OCT system records the image of the scan circle over 
the ONH immediately after acquiring the RNFL thickness data. Therefore, although we 




could not rule out the possibility of miniscule eye movements as the explanation for the 
cases in which significant horizontal shift of the peak contours were noted.  
Our study, therefore, was limited to assessing the prevalence with which 
significant horizontal deviation may occur, from whatever cause, with the Stratus OCT 
Fast RNFL scan in glaucoma patients and glaucoma suspects and to evaluating whether 
this finding is associated with certain demographic or glaucoma-related variables. We 
found horizontal contour deviation to be common in our patients.  When defining a 
significant deviation as 20
o
 or more either nasal or temporal to that of the normative 
database in both the superior and inferior contour peaks, the prevalence was 14.3% (95% 
CI 10%-19%).  We chose this cut-off value, because it usually caused the RNFL 
thickness contour to cut into the <5
th
 percentile of the normative database.  We also 
looked at a lower cut-off of 12
o
 or more, which increased the prevalence to 44.7% 
(95%CI 39%-51%).  With the larger cut-off, the majority (51%) of eyes had a nasal shift, 
while eyes with the smaller cut-off were more evenly distributed between nasal and 
temporal shifts.  An additional 44.3% (95%CI 38%-50%) of eyes had a significant shift 
(20
o
 or more) in either the superior (48) or inferior (76) peak contour.  Only a minority of 
subjects had significant horizontal shifts of both peaks bilaterally, and there was no 
significant correlation with demographic (age, race or sex) or glaucoma-related (C/D, 
neural rim or PSD) variables between eyes with and without significant horizontal 
deviation.  Furthermore, the presence of a significant horizontal deviation did not 
differentiate between glaucoma and glaucoma suspect subjects. 
Our findings are consistent with those of Ghadiali et al.
 
(61), who found wide 




associated with age, refractive error or signal strength, although they found better 
correlation of RNFL profiles between eyes than in our study.  These authors also 
suggested that a variation in pattern of axons or possibly in blood vessel location might 
account for the variable RNFL profile pattern.  
Supporting the theory of anatomical variation, as a partial explanation for the 
horizontal shift of contour peak, was the observation in our study that the majority of 
shifts of 20
o
 or more were in the nasal direction.  If the shifts were all due to scan circle 
misalignment (either operator error or miniscule eye movements), it is likely that this 
would be random with a more even distribution in the direction of peak shifts.  The fact 
remains, however, that the influence of circle misalignment cannot be ruled out with the 
Stratus OCT, since the image of the scan circle over the ONH and the RNFL thickness 
data are not acquired simultaneously.  While horizontal shift of the RNFL contour is 
associated with the quadrant and average RNFL thickness, we did not attempt to quantify 
this correlation.  In addition, we only considered the possible influence of translational 
misalignment of the circle scan (i.e., horizontal or vertical) and not rotational shifts of the 
eye on horizontal deviation.      
A limitation of our study, therefore, was the inability to rule out scan circle 
decentration as the explanation for the horizontal deviation in peak contours.  Even 
though we excluded eyes with gross scan circle misalignment, it is possible that sudden 
small eye movement between acquisition of the scan circle/ONH image and the actual 
OCT scan could have caused an undetected decentration of the ONH.  Our study does, 
however, suggest that significant horizontal deviation of peak contours is common with 




emphasizes the need for caution when interpreting the influence of horizontal deviation 
on clock hour segment thinning reported by Stratus OCT.   
The findings in the present study may not be applicable to the next generation of 
spectral domain OCT, such as the Cirrus-HD OCT, which eliminates the need for 
operator centering of the ONH and allows for precise centration of the scan circle around 
the ONH.  The algorithm with this technology creates a virtual 3.4mm scan circle around 
the ONH after processing the scan data, and the decreased acquisition time will reduce 
motion artifact from minuscule eye movements during scanning.  Further study, 
therefore, is needed to establish the prevalence of horizontal peak contour deviation with 
this newer technology and to better understand the mechanism behind it. 
A problem with the interpretation of the RNFL thickness results of current models 
is that there is a wide range in the number of retinal ganglion cells in the normal 
population and thus there is considerable overlap in RNFL measurements between 
normal eyes and eyes with early to moderate glaucoma.  Similarly, there is probably a 
wide variation in the location of the peak contours observed in the superior and inferior 
quadrants.  As a result, the ability to diagnose early RNFL damage may dependent on the 
ability to detect small RNFL thinning from baseline in each individual patient over time, 
rather than comparison to a normative database (as is current practice).  There are, 
however, very few longitudinal studies evaluating small changes in RNFL thickness 
measurements that may predict development of glaucoma or monitor its progression.   
For now, RNFL measurements are only used as an adjunct to ONH photography 
and VF testing to aid in glaucoma management.  A report put out my the American 




―information obtained from imaging devices is useful in clinical practice when analyzed 
in conjunction with other relevant parameters that define glaucoma diagnosis and 
progression.‖  The ―gold standard‖ for glaucoma diagnosis remains intraocular pressure 
measurement, standard automated perimetry(SAP) and ONH photography.  There are 
inherent problems with the current ―gold standard‖ measurements for glaucoma 
diagnosis.  Interpretation of ONH photographs is subjective and VF testing is highly 
variable depending on subject performance, while RNFL imaging measurements, based 
on a preprogrammed algorithm, are objective.  The ability of RNFL progression analysis 
to detect small changes in RNFL structure before SAP is promising for future early 
detection of glaucoma progression.  Current utilities of RNFL imaging include early 
diagnosis of glaucoma and documentation of baseline measurements, but VF testing and 
ONH photography remain the mainstays of following glaucoma progression.  
Most of the published studies thus far have focused on the ability of diagnostic 
imaging to differentiate between normal eyes and glaucomatous eyes that have 
documented VF defects.  The real utility of diagnostic imaging in clinical practice lies in 
the ability to detect early RNFL damage in glaucoma suspects before there is detectable 
VF loss.  The next step major step in expanding the utility of peripapillary imaging is to 
conduct longitudinal studies to evaluate the ability of these instruments to document 
RNFL change over time and whether early RNFL structural changes predict the 
development of VF defects.  The rapidly improving technology impedes conducting 
longitudinal studies because peripapillary measurements collected from prior models are 
not compatible with measurements from newer models (with the exception of the 




comparable with measurements taken from the Cirrus-HD OCT.  Furthermore, each new 
model has a different normative database for comparison.  This inherent problem with 
rapidly evolving technologies also inhibits using imaging derived RNFL baseline 





Future Study Proposal 
With the widespread use of computerized RNFL analysis in the diagnosis and 
management of glaucoma, it is important for the clinician to understand the data provided 
in order to accurately utilize the information in glaucoma management.  A major 
limitation of our present study using the time domain Stratus OCT model was the 
inability to rule-out scan circle decentration as an explanation of the horizontal peak 
contour displacement.  With the spectral domain Cirrus High Definition (HD)-OCT 
model, it will be possible to eliminate scan circle decentration because the scan circle is 
digitally created after processing of the RNFL data.   
The purpose of this next study will be to evaluate how common significant 
horizontal peak contour displacement (not due to decentration) from the normative 
database may be using the spectral domain Cirrus HD-OCT Fast RNFL scan in a practice 
with glaucoma patients and glaucoma suspects, to explore whether demographic or 
glaucoma-related variables are associated with this finding and to emphasize the 
importance of this finding when interpreting OCT data.  Our hypothesis is that horizontal 
peak contour displacement from the normative database observed on the Fast RNFL scan 
is a common occurrence because there is a range of distribution of peak contours due to 
anatomical variation, not necessarily related to glaucoma, and this displacement may lead 
to misclassification as glaucoma under current commercial OCT criteria (comparing an 
individual’s RNFL measurements to a normative database) resulting in over aggressive 
treatment for glaucoma.  Due to time constraints, it is not possible to perform a 




 The study design will be a prospective case series of consecutive patients seen at 
the Yale Eye Center, Department of Ophthalmology and Visual Science, New Haven, 
CT.  The inclusion criteria will be glaucoma patients and glaucoma suspects who undergo 
a Cirrus HD-OCT Fast RNFL scan between December 2008 and May 2009.  Exclusion 
criteria will include patients under 20 years of age (normative database is not available 
below this age), a superior or inferior peak contour amplitude < 100 μm (peak of the 
contour is difficult to identify below this amplitude), and signal strength of less than 6 
(analysis algorithms may fail on scans with low signal strength <5).  One eye from each 
subject will be randomly selected for analysis (using the ―random sample of cases‖ 
function in SPSS), although both eyes will be studied to determine bilaterality of 
findings, and the most recent test will be chosen for patients who have more than one test.  
This study is pending approval by the Yale University HIC and conforms to the 
Declaration of Helsinki research on human subjects and HIPPA.   
An experienced technician will obtain the circumpapillary RNFL thickness profile 
with a Cirrus HD-OCT system (Carl Zeiss Meditec, Dublin, CA) using the Fast RNFL 
scan pattern.  Each study will be evaluated for signal strength, amplitude and horizontal 
position of the superior and inferior peak contours relative to the aged-matched normative 
database.  The exact horizontal distance between the peaks of the patient’s RNFL profile 
and that of the normative database will be measured digitally using EyeRoute software 
(Topcon Medical Systems, Inc., Paramus, NJ) which allows measurement of distances in 
mm, which will then be converted to degrees.  A significant horizontal shift of the peak 
contour will be defined as 20
o
 (1.7mm) or greater nasal or temporal to the corresponding 




significant horizontal deviation if there is a 20
o
 or greater shift of both the superior and 









Figure 1: *A. Schematic section through the eye and optic nerve head.  *B. 
Schematic cross-section of the layers of the retina. 
*Images A and B are from Webvision: Simple Anatomy of the Retina.  John 






Figure 2: Heidelberg Retina Tomograph (HRT) standard printout in a normal control 
showing the retinal nerve fiber layer (RNFL) thickness profile (dotted black line) against 
the age stratified normative database (green, yellow, red) in the bottom right, obtained 





Figure 3: Stratus OCT standard printout in a normal control showing the fundus image 
with scan circle centration (right corner), peripapillary retinal cross section image (far 
right corner), and circumpapillary RNFL thickness profile (black line) against age 
stratified normative database (green, yellow, red) (upper left), obtained using a Stratus 





Figure 4: A. Stratus OCT circumpapillary RNFL thickness profile with horizontal 
deviation* in a glaucoma patient with a cup-disc ratio of 0.9 and documented visual field 
scotoma (i.e. true glaucoma).  B. Stratus OCT circumpapillary RNFL thickness profile with 
horizontal deviation* in a glaucoma suspect with a cup-disc ratio of 0.3 and no visual field 
defect (i.e. RNFL thinning possibly due to peak shifts).   
*20
o
 or more shift nasal or temporal to the corresponding peak contour of the normative 









Figure 5: Circumpapillary RNFL thickness profile (black line) against age 
stratified normative database (green, yellow, red), obtained using a Stratus OCT 
3000 system, showing nasal shifts >20
o
 in the superior and inferior peaks, 
classified as a significant horizontal deviation. 
 
Nasal Shift Nasal Shift 
1.77mm=20.7o 2.67mm=31.2o 
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